Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1511 of 6351
-
Can antibiotics trigger Kidney-Harming crystals? a study investigates
Knowledge-focused Recruiting nowThis study examines in hospitalized patients, treated with sulfamethoxazole, high dose ciprofloxacin or high dose iv amoxicillin, the incidence of drug-induced urinary crystal formation and its association with acute kidney injury development.
Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
New hope for Hard-to-Treat ovarian cancer: drug combo enters human testing
Disease control Recruiting nowThe purpose of this study is to learn about the safety and tolerability of Cirtuvivint in combination with Olaparib in platinum resistant ovarian cancer. The study also aims to determine the recommended dose of the combination therapy. If a participant is a good fit for the stud…
Phase 1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New shot aims to tame dangerously high blood fats
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of solbinsiran in lowering triglycerides and other lipid measures compared to placebo in participants with severe hypertriglyceridemia. Participants will receive two subcutaneous injections.
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Radiation may control breast cancer when surgery Isn't an option
Disease control Recruiting nowThe purpose of this study is to find out if adding radiation therapy to routine medications for breast cancer helps in reducing and preventing the cancer from getting worse. Patients with a locally advanced breast cancer who cannot, or do not want to, undergo surgery are eligible…
Sponsor: Alexander Stessin • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a simple therapy help kids with a rare form of cerebral palsy walk and balance better?
Disease control Recruiting nowAtaxic cerebral palsy (CP) is the least common subtype of CP and it is primarily caused by cerebellar damage that results in hypotonia, impaired balance, poor coordination, tremors, wide-based gait, and significant difficulties in trunk stability and uncontrolled movements. These…
Sponsor: Lahore University of Biological and Applied Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a diabetes pill slow lung cancer? new trial aims to find out
Disease control Not yet recruitingThe goal of this clinical trial The goal of this clinical trial is to evaluate whether SGLT2 inhibitor drugs can extend overall survival or delay the progression of the tumor in patients with both advanced lung cancer and diabetes. It will also check if these drugs are safe for …
Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Immune cell double punch takes on Hard-to-Treat tumors
Disease control Recruiting nowThis is an open-label, single-arm clinical study designed to evaluate the safety and preliminary efficacy of Targeted Activated DC combined with CAR-T therapy in patients with Advanced Solid Cancers.This combination therapy activates dendritic cells (DCs) to precisely target the …
Early phase 1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a womb-relaxing drug boost IVF success? new trial aims to find out.
Symptom relief Recruiting nowThis study aims to evaluate the efficacy of atosiban in patients with previous pregnancy failure and abnormal uterine contractions during the peri-embryo transfer period in assisted reproductive technology. The main questions it aims to answer are: * Does the use of atosiban in …
Sponsor: Northwest Women's and Children's Hospital, Xi'an, Shaanxi • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New shot aims to stop peanut allergy emergencies
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety, pharmacokinetics, and effectiveness of MY006, a therapy designed to prevent severe or potentially life-threatening allergic reactions caused by accidental peanut intake. In the first part of the study, adult participants …
Phase 1 • Sponsor: Mabylon AG • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New combo aims to shield rheumatoid arthritis patients from heart attacks
Disease control Recruiting nowThe rationale of our study is to observe the incidence of MACE in RA patients treated with tofacitinib along with statins with one or more cardiovascular disease risks. PRIMARY OBJECTIVE * To determine the incidence of MACE in Rheumatoid Arthritis patients with moderate to high…
Phase 4 • Sponsor: Shaikh Zayed Hospital, Lahore • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New Mini-Open spine surgery aims to cut recovery time for spinal stenosis patients
Symptom relief Not yet recruitingThis clinical study aims to find out if a modified mini-open spine surgery (modified mini-open transforaminal lumbar interbody fusion,mMO-TLIF) is as good as, or better than, the traditional open surgery (traditional transforaminal lumbar interbody fusion,traditional TLIF) for tr…
Sponsor: The First People's Hospital of Lianyungang • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Virtual reality could replace pills for Kids' casting pain
Symptom relief Recruiting nowThis prospective randomized controlled trial will evaluate whether virtual reality can reduce procedural distress in children undergoing cast application for forearm fractures. Children will be assigned to either a virtual reality group or a standard care group. In the virtual re…
Sponsor: Başakşehir Çam & Sakura City Hospital • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New combo pill aims to protect kidneys in High-Risk patients
Disease control OngoingInternational, Multicenter and Double-Blind study. The purpose is to measure the effect of baxdrostat in combination with dapagliflozin compared with baxdrostat/placebo on albuminuria, as well as safety, in participants with chronic kidney disease and high blood pressure.
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for tough arthritis cases: experimental drug enters Mid-Stage trial
Disease control Recruiting nowThis study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to severe rheumatoid arthritis (RA) who have an inadequate response or intolerance to TNF and/or JAK inhibitors.
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
UK launches massive endometriosis study to unlock secrets of the painful condition
Knowledge-focused Recruiting nowApproximately 1.5 million people in the UK, and 200 million globally live with endometriosis, and it is estimated to affect 1 in 10 women of reproductive age. Endometriosis is a chronic pain condition where the lining of the uterus (endometrium) grows in areas outside the uterus.…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New eye drop takes on pesky eyelash mites
Disease control Recruiting nowThis is a randomized, double-masked, placebo-controlled, dose-ranging, parallel-group, multi-center study designed to evaluate the safety and efficacy of GLK-321 in patients with Demodex blepharitis.
Phase 2 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug offers hope for breast cancer patients suffering from hot flashes
Symptom relief Recruiting nowThis is a phase II, randomized, double-blinded, placebo-controlled trial designed to evaluate the efficacy of fezolinetant (45 mg a day) vs. placebo in reducing moderate to severe vasomotor symptoms (VMS) in breast cancer survivors on endocrine therapy (tamoxifen, aromatase inhib…
Phase 2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Could a pill and gel combo restore skin color in vitiligo?
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, and safety of SHR0302 tablets as single therapy or in combination with SHR0302 Base gel for patients with non-segmental vitiligo.
Phase 2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New heart ablation method could be safer, trial aims to prove
Disease control Recruiting nowThe goal of this clinical trial is to evaluate whether pulsed field ablation (PFA) using the novel VOLT catheter is as safe and effective as conventional thermal ablation (radiofrequency or cryotherapy) for the treatment of atrial fibrillation (AF) in adult patients undergoing th…
Sponsor: Sebastien Knecht • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New shot shows promise against tough cancers
Disease control Recruiting nowThis study aims to find the right dosage and evaluate the safety and effectiveness of the drug IPN60300 in adults with advanced solid tumours, which are cancers that have spread to other parts of the body from their original location. All participants will receive the drug by inj…
Phase 1/2 • Sponsor: Ipsen • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC